1. Home
  2. KEQU vs NRXP Comparison

KEQU vs NRXP Comparison

Compare KEQU & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$36.02

Market Cap

110.9M

Sector

Industrials

ML Signal

HOLD

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

HOLD

Current Price

$3.92

Market Cap

99.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
NRXP
Founded
1906
2015
Country
United States
United States
Employees
N/A
29
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.9M
99.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
KEQU
NRXP
Price
$36.02
$3.92
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$38.25
AVG Volume (30 Days)
1.3K
1.7M
Earning Date
03-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.09
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
$2,547.84
Revenue Next Year
N/A
$1,591.73
P/E Ratio
$17.49
N/A
Revenue Growth
7.72
N/A
52 Week Low
$33.70
$1.65
52 Week High
$60.89
$5.06

Technical Indicators

Market Signals
Indicator
KEQU
NRXP
Relative Strength Index (RSI) 43.59 55.17
Support Level $37.04 $1.89
Resistance Level $41.25 $5.06
Average True Range (ATR) 0.69 0.46
MACD -0.46 -0.02
Stochastic Oscillator 15.96 48.06

Price Performance

Historical Comparison
KEQU
NRXP

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: